In this review, we will discuss the evidence for the novel role of FST, MST and other related proteins in modulating TGF-β signaling and adipocyte browning to explore possible therapeutic avenues for the treatment of obesity and associated metabolic disorders. This evidence concerns the gene FST and metabolic disease.